Financhill
Sell
32

AMMX Quote, Financials, Valuation and Earnings

Last price:
$0.24
Seasonality move :
68.35%
Day range:
$0.24 - $0.24
52-week range:
$0.09 - $0.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.20x
P/B ratio:
0.87x
Volume:
--
Avg. volume:
78.3K
1-year change:
77.19%
Market cap:
$3.5M
Revenue:
--
EPS (TTM):
--
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue $9.8M $12.7M $12.3M $24.7M $19.2M
Revenue Growth (YoY) 12.5% 29.16% -2.97% 101.33% -22.25%
 
Cost of Revenues $6.7M $10.3M $10.5M $19.7M $14.7M
Gross Profit $3.1M $2.4M $1.8M $5M $4.5M
Gross Profit Margin 31.76% 18.65% 14.41% 20.34% 23.35%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2M $1.4M $1.4M $1.9M $2.7M
Other Inc / (Exp) $131.2K -$351.5K -$297.1K $158.1K $153.6K
Operating Expenses $1.2M $1.4M $1.4M $1.9M $2.7M
Operating Income $2M $933.7K $370.1K $3.2M $1.8M
 
Net Interest Expenses $828.6K $747.9K $1M $943.4K $680.6K
EBT. Incl. Unusual Items $1.3M -$165.6K -$974.4K $2.4M $1.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $368.4K -$75.4K -$391.7K $746.9K $364.5K
Net Income to Company $885.6K -$90.3K -$582.7K $1.6M $871.1K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $885.6K -$90.3K -$582.7K $1.6M $871.1K
 
Basic EPS (Cont. Ops) $0.06 -$0.01 -$0.04 $0.11 $0.06
Diluted EPS (Cont. Ops) $0.06 -$0.01 -$0.04 $0.11 $0.06
Weighted Average Basic Share $15.1M $14.8M $14.5M $14.6M $14.8M
Weighted Average Diluted Share $15.1M $14.8M $14.5M $14.6M $14.8M
 
EBITDA $3.3M $1.8M $1.4M $4.2M $2.8M
EBIT $2.1M $582.2K $73K $3.3M $1.9M
 
Revenue (Reported) $9.8M $12.7M $12.3M $24.7M $19.2M
Operating Income (Reported) $2M $933.7K $370.1K $3.2M $1.8M
Operating Income (Adjusted) $2.1M $582.2K $73K $3.3M $1.9M
Period Ending 2019-03-31 2020-03-31 2021-03-31 2022-03-31 2023-03-31
Revenue $2.4M $1.4M $4M $5M $3.2M
Revenue Growth (YoY) 37.38% -41.14% 180.14% 22.88% -35.19%
 
Cost of Revenues $1.8M $994.3K $2.9M $3.7M $2.4M
Gross Profit $642.2K $444.2K $1.2M $1.2M $818.3K
Gross Profit Margin 26.28% 30.88% 29.08% 25.23% 25.5%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $285.9K $357.4K $383.5K $692.8K $475.5K
Other Inc / (Exp) -$566.3K -- -$2.3K -$14.8K -$76.9K
Operating Expenses $285.9K $357.4K $383.5K $692.8K $475.5K
Operating Income $356.3K $86.9K $788.2K $556.3K $342.8K
 
Net Interest Expenses $179.2K $261.1K $267.1K $177.8K $123.5K
EBT. Incl. Unusual Items -$389.3K -$174.3K $518.9K $363.7K $142.4K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$106.6K -$46.2K $153.1K $105.4K $41.3K
Net Income to Company -$282.6K -$128.1K $365.8K $258.3K $101.1K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$282.6K -$128.1K $365.8K $258.3K $101.1K
 
Basic EPS (Cont. Ops) -$0.02 -$0.01 $0.03 $0.02 $0.01
Diluted EPS (Cont. Ops) -$0.02 -$0.01 $0.03 $0.02 $0.01
Weighted Average Basic Share $15.1M $15.1M $14.5M $14.6M $14.8M
Weighted Average Diluted Share $15.1M $15.1M $14.5M $14.6M $14.8M
 
EBITDA $61.8K $424.5K $1M $729.6K $522.8K
EBIT -$210K $86.9K $786K $541.5K $265.9K
 
Revenue (Reported) $2.4M $1.4M $4M $5M $3.2M
Operating Income (Reported) $356.3K $86.9K $788.2K $556.3K $342.8K
Operating Income (Adjusted) -$210K $86.9K $786K $541.5K $265.9K
Period Ending 2019-03-31 2020-03-31 2021-03-31 2022-03-31 2023-03-31
Revenue $10.2M $11.6M $14.9M $25.6M $17.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.2M $9.5M $12.4M $20.5M $13.4M
Gross Profit $3M $2.2M $2.5M $5.1M $4.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1M $1.5M $1.4M $2.2M $2.5M
Other Inc / (Exp) -$435.2K $130.9K -$726.4K $145.6K $91.6K
Operating Expenses $1.1M $1.5M $1.4M $2.2M $2.5M
Operating Income $1.8M $664.2K $1.1M $2.9M $1.5M
 
Net Interest Expenses $849K $745.8K $948.8K $854.1K $626.4K
EBT. Incl. Unusual Items $557.2K $49.4K -$603.8K $2.2M $1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $171.1K -$14.9K -$372.4K $699.3K $394.5K
Net Income to Company $73.8K $64.2K -$88.8K $1.5M $713.8K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $386.1K $64.2K -$231.4K $1.5M $619.7K
 
Basic EPS (Cont. Ops) $0.03 $0.00 -$0.02 $0.11 $0.04
Diluted EPS (Cont. Ops) $0.03 $0.00 -$0.02 $0.11 $0.04
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.3M $2.1M $1.6M $3.9M $2.5M
EBIT $1.4M $795.1K $345K $3.1M $1.6M
 
Revenue (Reported) $10.2M $11.6M $14.9M $25.6M $17.5M
Operating Income (Reported) $1.8M $664.2K $1.1M $2.9M $1.5M
Operating Income (Adjusted) $1.4M $795.1K $345K $3.1M $1.6M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $1.4M $4M $5M $3.2M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $994.3K $2.9M $3.7M $2.4M --
Gross Profit $444.2K $1.2M $1.2M $818.3K --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $357.4K $383.5K $692.8K $475.5K --
Other Inc / (Exp) -- -$2.3K -$14.8K -$76.9K --
Operating Expenses $357.4K $383.5K $692.8K $475.5K --
Operating Income $86.9K $788.2K $556.3K $342.8K --
 
Net Interest Expenses $261.1K $267.1K $177.8K $123.5K --
EBT. Incl. Unusual Items -$174.3K $518.9K $363.7K $142.4K --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$46.2K $153.1K $105.4K $41.3K --
Net Income to Company -$128.1K $365.8K $258.3K $101.1K --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$128.1K $365.8K $258.3K $101.1K --
 
Basic EPS (Cont. Ops) -$0.01 $0.03 $0.02 $0.01 --
Diluted EPS (Cont. Ops) -$0.01 $0.03 $0.02 $0.01 --
Weighted Average Basic Share $15.1M $14.5M $14.6M $14.8M --
Weighted Average Diluted Share $15.1M $14.5M $14.6M $14.8M --
 
EBITDA $424.5K $1M $729.6K $522.8K --
EBIT $86.9K $786K $541.5K $265.9K --
 
Revenue (Reported) $1.4M $4M $5M $3.2M --
Operating Income (Reported) $86.9K $788.2K $556.3K $342.8K --
Operating Income (Adjusted) $86.9K $786K $541.5K $265.9K --
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Cash and Equivalents $197.8K $114.5K $407.9K $995.6K $1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $631.8K $589.7K $768.4K $1.2M $993.9K
Inventory $2.7M $4.8M $5.9M $5.2M $6.3M
Prepaid Expenses -- -- -- -- --
Other Current Assets $289.1K $207K $198.5K $313K $318.8K
Total Current Assets $3.8M $5.7M $7.2M $7.7M $8.6M
 
Property Plant And Equipment $5.7M $5.2M $4.7M $2.7M $4.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $234.1K $489.6K $453.4K $391.3K $374.1K
Total Assets $9.7M $11.4M $12.5M $10.8M $13.1M
 
Accounts Payable $1.3M $531.8K $620.2K $560.1K $1.2M
Accrued Expenses $118.3K $79.8K $231.3K $264.5K $322.1K
Current Portion Of Long-Term Debt $296.6K $794.6K $6.8M $4M $2.8M
Current Portion Of Capital Lease Obligations -- -- -- -- $129.1K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.7M $1.9M $8.1M $5.2M $4.7M
 
Long-Term Debt $5.4M $7.2M $2.8M $1.7M $2.9M
Capital Leases -- -- -- -- --
Total Liabilities $7.5M $9.3M $10.9M $7.5M $8.9M
 
Common Stock $753.4K $15.1K $14.6K $14.6K $14.8K
Other Common Equity Adj -- -- -- -- --
Common Equity $2.2M $2.1M $1.6M $3.3M $4.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.2M $2.1M $1.6M $3.3M $4.2M
 
Total Liabilities and Equity $9.7M $11.4M $12.5M $10.8M $13.1M
Cash and Short Terms $197.8K $114.5K $407.9K $995.6K $1M
Total Debt $5.7M $8M $9.6M $5.6M $5.7M
Period Ending 2019-03-31 2020-03-31 2021-03-31 2022-03-31 2023-03-31
Cash and Equivalents $58K $174.5K $337.6K $625.5K $939.7K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $733K $851.5K $1.8M $1.5M $791.6K
Inventory $4.8M $6.7M $6.6M $6.7M $6.9M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1M $288K $232.3K $239.2K $220.3K
Total Current Assets $6.7M $8M $9M $9M $8.8M
 
Property Plant And Equipment $5.5M $4.7M $4.1M $3.2M $3.8M
Long-Term Investments -- -- -- -- $177K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $234.1K $474.4K $435.9K $368K $229.9K
Total Assets $12.4M $13.7M $13.5M $12.6M $13.1M
 
Accounts Payable $2.6M $680.6K $1.3M $1.2M $1.4M
Accrued Expenses $106K $106.7K $347.3K $233K $200.4K
Current Portion Of Long-Term Debt $60K $15K $6.4M $4.3M $2.9M
Current Portion Of Capital Lease Obligations -- -- -- $129.1K $129.1K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.7M $802.3K $8.6M $6.1M $4.6M
 
Long-Term Debt $6.5M $9.4M $2.9M $1.6M $3.1M
Capital Leases -- -- -- -- --
Total Liabilities $9.5M $11.1M $11.5M $9.1M $9M
 
Common Stock $754K $753.4K $14.6K $14.6K $14.8K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.9M $2.5M $2M $3.5M $4.1M
 
Total Liabilities and Equity $12.4M $13.7M $13.5M $12.6M $13.1M
Cash and Short Terms $58K $174.5K $337.6K $625.5K $939.7K
Total Debt $6.5M $9.4M $9.3M $5.9M $6M
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Net Income to Stockholders $885.6K -$90.3K -$582.7K $1.6M $871.1K
Depreciation & Amoritzation $1.2M $1.2M $1.3M $916.3K $836K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$182.6K $42.1K -$178.7K -$393.9K $168.4K
Change in Inventories $381.8K -$2.1M -$1M $2.9M -$526.2K
Cash From Operations $1.4M -$1.5M -$256.1K $5.8M $1.9M
 
Capital Expenditures $2.4M $795.2K $753.8K $1.2M $2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.3M -$795.2K -$753.8K -$1.2M -$2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3.1M $6.9M $4.6M $2.5M $3M
Long-Term Debt Repaid -$2.6M -$5.1M -$3.3M -$3.6M -$2.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $459.5K -$20K -$297K $85K
Cash From Financing $503.2K $2.2M $1.3M -$4M $87.7K
 
Beginning Cash (CF) $553.6K $197.8K $114.5K $407.9K $995.6K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$355.9K -$83.3K $293.4K $587.7K $36.6K
Ending Cash (CF) $197.8K $114.5K $407.9K $995.6K $1M
 
Levered Free Cash Flow -$990.2K -$2.3M -$1M $4.5M -$51.1K
Period Ending 2019-03-31 2020-03-31 2021-03-31 2022-03-31 2023-03-31
Net Income to Stockholders -$282.6K -$128.1K $365.8K $258.3K $101.1K
Depreciation & Amoritzation $271.8K $337.7K $258.2K $188.1K $256.9K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$84.3K $110.5K -$994.9K -$297.7K $202.3K
Change in Inventories -$2.1M -$1.9M -$757.3K -$1.2M -$457.7K
Cash From Operations -$419.8K -$1.6M -$229K -$597.5K $276.1K
 
Capital Expenditures $97K $39K $6.5K $135.4K $154.3K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$50.8K -$39K $298.3K -$135.4K -$154.3K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $6.1M $2.9M $542.4K $691.6K $470K
Long-Term Debt Repaid -$5.7M -$1.2M -$252.9K -$434.4K -$507.4K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$17.5K $155.3K $105.5K -$177K
Cash From Financing $330.8K $1.7M -$139.6K $362.7K -$214.4K
 
Beginning Cash (CF) $197.8K $114.5K $407.9K $995.6K $1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$139.8K $72.5K -$70.3K -$370.1K -$92.5K
Ending Cash (CF) $58K $187K $337.6K $625.5K $939.7K
 
Levered Free Cash Flow -$516.8K -$1.6M -$235.5K -$732.9K $121.8K
Period Ending 2019-03-31 2020-03-31 2021-03-31 2022-03-31 2023-03-31
Net Income to Stockholders $73.8K $64.2K -$88.8K $1.5M $713.8K
Depreciation & Amoritzation $1.5M $1.3M $1.2M $846.3K $904.7K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$146.5K $236.9K -$1.3M $303.3K $668.4K
Change in Inventories -$1.4M -$2M $154.2K $2.4M $239.5K
Cash From Operations $2M -$2.7M $1.1M $5.4M $2.8M
 
Capital Expenditures $2.3M $737.2K $721.3K $1.4M $2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.1M -$783.4K -$416.6K -$1.7M -$2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $8.4M $3.7M $2.2M $2.7M $2.8M
Long-Term Debt Repaid -$8.3M -$603.7K -$2.3M -$3.8M -$2.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $152.7K -$346.7K -$197.5K
Cash From Financing $76.6K $3.6M -$509.6K -$3.5M -$489.4K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$63K $129K $150.6K $287.9K $314.2K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$317K -$3.4M $355.5K $4M $803.6K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -$128.1K $365.8K $258.3K $101.1K --
Depreciation & Amoritzation $337.7K $258.2K $188.1K $256.9K --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $110.5K -$994.9K -$297.7K $202.3K --
Change in Inventories -$1.9M -$757.3K -$1.2M -$457.7K --
Cash From Operations -$1.6M -$229K -$597.5K $276.1K --
 
Capital Expenditures $39K $6.5K $135.4K $154.3K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$39K $298.3K -$135.4K -$154.3K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.9M $542.4K $691.6K $470K --
Long-Term Debt Repaid -$1.2M -$252.9K -$434.4K -$507.4K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$17.5K $155.3K $105.5K -$177K --
Cash From Financing $1.7M -$139.6K $362.7K -$214.4K --
 
Beginning Cash (CF) $114.5K $407.9K $995.6K $1M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $72.5K -$70.3K -$370.1K -$92.5K --
Ending Cash (CF) $187K $337.6K $625.5K $939.7K --
 
Levered Free Cash Flow -$1.6M -$235.5K -$732.9K $121.8K --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock